9 February 2018 - The White House released a 30 page white paper Friday morning that promotes easing government regulations and spurring innovation to lower drug prices, while roundly rejecting the idea of government price setting.

The document, written by the White House’s Council of Economic Advisers, comes on the heels of reports that President Trump will include a list of proposals to lower patients’ out-of-pocket spending on drugs in the budget he will release next week.

The paper blames high drug spending in the United States — where pharmaceutical products cost more than in any other developed country — on nations that have fixed drug prices and “free ride” off the innovation of companies that pay for drug research and development by raising their U.S. prices.

Read Washington Post article